CYCN Stock Catalyst: Cyclerion Therapeutics Announces Strategic Agreement with Medsteer for CYC-126

Jan 5, 2026 · 11:06am ET

Integration aims to enhance treatment for resistant depression.

Max move

+75.4%

High of day $2.35

Sparker timei

11:06am ET

CYCN · Jan 5, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Medsteer announced on January 05, 2026, a strategic agreement to integrate Medsteer's technology into Cyclerion's lead program, CYC-126, aimed at treating patients with treatment-resistant depression.

The collaboration focuses on leveraging Medsteer's technology to potentially improve the efficacy and delivery of CYC-126.

Cyclerion Therapeutics has a free float of 3,070,500 shares and 3,806,200 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time CYCN sparks.

Download Sniper App →

Catch the next CYCN-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →